PHILADELPHIA (WPVI) -- Everyone knows it's cold it is outside. The entire Philadelphia region has remained below freezing for the seventh day in a row, with little relief in sight. But we are tapping ...
Maze Therapeutics, a kidney disease therapy developer, recently IPO-ed with a market cap of $487mn and significant early-stage investor backing. Lead asset MZE829 targets APOL1 Kidney Disease, showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results